Closing Bell: Nervgen Pharma Corp up on Tuesday (NGEN)

In trading today, Nervgen Pharma Corp shares closed at $3.10 after opening the day at $2.90. It traded at a low of $2.88 to a high of $3.15.

Shares advanced 9.15 percent from the previous day's close of $2.84.

Today across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -3.00% at 5186.33, the Dow Jones Industrial Average closed -2.60% at 38703.27 and the Nasdaq Composite closed -3.43% at 16200.08.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

A total of 193,316 shares was traded during the last trading day, with total trades of 315, with an average volume of 74,642 over the last 5 days.

Trading across the entire TSX-V saw 3,772 price advancers against 1,443 declines and 86 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 12 months, Nervgen Pharma Corp's shares have soared 85.63 percent, while this year, they have boosted 14.81%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $198.59 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Nervgen Pharma Corp's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..